This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

REPORT OF THIRTY-THREE CASES TREATED WITH ANTISTREPTOCOCCUS (ERYSIPELAS) SERUM

R. CANNON ELEY, M.D.

Am J Dis Child. 1930;39(3):529-535.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In any disease in which the mortality rate is unusually high, numerous and not altogether successful methods of treatment are likely to be advocated. This has been true of erysipelas in infants. Morse¹ reported 90 per cent mortality in infants; Erdman² reported 39.7 per cent; while Schaffer and Rothman³ gave the following results: infants under 1 month of age, 80 per cent; under 6 months, 53 per cent; from 6 to 12 months, 47 per cent, and from 1 to 2 years, 14 per cent. As regards the influence of different forms of therapy, Knox⁴ reported a mortality rate of 60 per cent in infants under 6 months of age treated by local measures; Robertson⁵ quoted 65 per cent in infants under 12 months of age treated by exsanguination-transfusion; Borovsky,⁶ 29 per cent by the use of a 2 per cent solution of mercurochrome-220 . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

From the Infants' and Children's Hospitals and the Department of Pediatrics, Harvard Medical School.

Footnotes
Submitted for publication, Nov. 4, 1929.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?